文献速递生殖医学母胎医学

重新解读STAR试验:PGT-A与胚胎损耗

Shooting STAR: reinterpreting the data from the 'Single Embryo TrAnsfeR of Euploid Embryo' randomized clinical trial.
PubMed 文献 · Reprod Biomed Online · 2020-01-25

本文重新分析「Single Embryo TrAnsfeR of Euploid Embryo」(STAR)随机对照试验数据,通过比较PGT-A组移植「整倍体」胚胎的活产率与对照组具有着床潜能胚胎的理想活产率,发现PGT-A可能导致有发育潜能胚胎的活产率从82.2%降至50.0%,提示PGT-A与胚胎损耗相关。

要点

  • STAR试验中PGT-A组与对照组意向性治疗活产率相似。
  • 模型分析显示PGT-A使有潜能胚胎活产率从82.2%降至50.0%。
  • PGT-A可能因误诊或活检损伤造成胚胎损耗。

核心结论

  • PGT-A可能因误诊或活检相关胚胎损伤而导致有发育潜能胚胎的损耗。

研究设计与样本

  • 对Munné等STAR随机对照试验数据的重新解读,利用该试验报告的遗传检测结果进行模型估算。

主要发现

  • PGT-A组移植「整倍体」胚胎的活产率与对照组具有着床潜能胚胎的理想活产率相比,从82.2%降至50.0%。

临床怎么用

  • 临床解读PGT-A结果时需考虑误诊和活检损伤可能降低有潜能胚胎的活产率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Preimplantation genetic testing for aneuploidy (PGT-A) still remains controversial in clinical practice. Recently, the randomized controlled trial, 'Single Embryo TrAnsfeR of Euploid Embryo' (STAR) by Munné and coworkers showed a similar live birth rate per intention to treat in the two study groups (PGT-A and controls). A wrong diagnosis and/or biopsy-related damage to the embryo might underlie these results. To assess the impact of these factors on the efficiency of PGT-A, the live birth rate of 'euploid' embryos transferred in the PGT-A group was compared with its ideal value, namely the live birth rate of embryos with the potential to implant and to give rise to a baby in the control group. This estimate has been derived using the results of the genetic testing reported in the STAR trial. According to this model, the STAR trial has demonstrated that transferring only blastocysts classified as 'euploid' after PGT-A leads to a reduction from 82.2% to 50.0% of the live birth rate for competent embryos, thus supporting the idea that PGT-A is associated with some embryo wastage.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Pagliardini L, Viganò P, Alteri A, et al. Shooting STAR: reinterpreting the data from the 'Single Embryo TrAnsfeR of Euploid Embryo' randomized clinical trial. Reprod Biomed Online. 2020. PMID: 32273162. doi:10.1016/j.rbmo.2020.01.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。